COMP <GO>
CTOR vs ATNM // EV/EBITDA & P/E VALUATION
Citius Oncology Inc. (NASDAQ) VS. Actinium Pharmaceuticals Inc. (Delaware) (NYSE) • 15-METRIC TALLY: CTOR 1
— ATNM 2
■ METRIC PARITY
LAST: $0.53 (-8.20%) • MKT CAP: $49.2M
valuation
—
LAST: $1.53 (+10.87%) • MKT CAP: $48.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTOR VS. ATNM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTOR | ATNM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.16% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | ATNM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 61.0 | -31.95 | ATNM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $49.2M | $48.1M | $1.1M | CTOR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTOR REV | ATNM REV | CTOR GROSS % | ATNM GROSS % | CTOR FCF | ATNM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $90.0K | — | — | -$5.5M | -$24.7M |
| FY 2024 | $0 | $0 | — | — | $126.4K | -$33.1M |
| FY 2023 | $0 | $81.0K | — | — | -$601.3K | -$47.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTOR // BETA —
ATNM // BETA —